HEXO Corp

HEXO Corp. engages in the provision of cannabis and cannabis products. The company was founded by Sébastien St. Louis and Adam Miron on October 29, 2013 and is headquartered in Gatineau, Canada.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Hydropothecary is a licensed producer of medical marijuana under Health Canada’s Access to Cannabis for Medical Purposes Regulations.Their leadership team brings proven scientific, financial, regulatory and entrepreneurial expertise to the rapidly evolving Canadian medical marijuana industry.Hydropothecary is an award-winning medical cannabis producer located on a 143-acre farm in Gatineau, Quebec, in the National Capital Region. Their focus is on product innovation, advanced natural growing techniques, client health and safety, and exceptional customer service. They take their commitment to customers seriously, offering exceptional packaging, courier delivery in Canada (Saturdays where available) and their bilingual, 24-hour customer service.

Tilray Brands

So, it's settled: Canadian cannabis producer Tilray (NASDAQ: TLRY ) plans to acquire rival Hexo (NASDAQ: HEXO ). It's debatable, however, whether this is actually a good idea.

Is Tilray Stock a Buy or Sell? Here's My Call.

Analysts at Canaccord Genuity (TSX:CF, LSE:CF) have lowered their price target for Tilray Brands after the company announced it is acquiring its strategic partner HEXO for US$56 million in tandem with the release of its fiscal 3Q 2023 results earlier this week. In a note to clients, the analysts wrote that their updated price target was US$4.25, down from US$5, with a ‘Buy' rating.

Tilray Brands price target lowered after 3Q earnings and HEXO acquisition announcement

HEXO Corp shares fell more than 25% on Tuesday after the company revealed it will be acquired by Canadian cannabis market leader Tilray Brands for $56 million in an all-stock deal. After initially spiking on Monday to US$1.64 on rumors of the acquisition, HEXO's share price reversed sharply on confirmation of the deal.

HEXO shares reverse sharply on Tilray acquisition

Tilray Brands (NASDAQ: TLRY ) announced it is acquiring rival cannabis company Hexo (NASDAQ: HEXO ) as the industry continues to consolidate. The announcement was made in Tilray's earnings release.

HEXO Stock Alert: Tilray to Acquire Hexo in $56 Million Deal

Tilray Brands Inc. TLRY, +5.38% TLRY, +6.27% stock is down 8% in premarket trades Tuesday after the cannabis company posted a wider-than-expected loss, missed its revenue estimate and said it would buy fellow Canadian cannabis company Hexo Corp. HEXO, +30.16% for $56 million in an all-stock deal. Hexo stock is down 23%.

Tilray, Hexo stocks fall sharply after M&A deal

Tilray plans to acquire Hexo for $56 million. The two companies entered into a strategic alliance last year.

Is Tilray Stock a Buy With Its Acquisition of Hexo?

Shares of Tilray Inc (NASDAQ: TLRY) is trading down in extended hours after the cannabis company said it swung to a loss in its third financial quarter. Tilray Q3 financial highlights Tilray continues to expect its operating segments to deliver positive free cash flow in FY23.

Tilray is buying HEXO Corp despite Q3 loss

Delivered $145.6 Million in Net Revenue and 16 th Consecutive Quarter of Positive Adjusted EBITDA

CORRECTION--Tilray Brands Reports Third Quarter Fiscal Year 2023 Financial Results and Announces Accretive Acquisition of 100% of HEXO Corp.

Canadian pot producer Tilray Brands Inc. on Monday said it would buy rival Hexo Corp. for $56 million, after years of losses, steep competition and stalled federal reform in the U.S. have weighed on the industry's growth prospects.

Tilray wants to buy Hexo, marking further Canadian cannabis consolidation

Tilray Brands will acquire its rival HEXO Corp for US$56 million through the issuance of 0.4352 Tilray shares for each outstanding HEXO share, the company announced along with the release of its fiscal third quarter 2023 results.  The acquisition will strengthen Tilray's leading position in the Canadian cannabis market to a 12.9% pro-forma market share, the company said.

Tilray Brands to acquire rival cannabis company HEXO for US$56M

Tilray Brands Reports Third Quarter Fiscal Year 2023 Financial Results and Announces Accretive Acquisition of 100% of HEXO Corp.

GATINEAU, Québec--(BUSINESS WIRE)--HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) (“HEXO” or the “Company”) announces that it has entered into a definitive arrangement agreement (the “Arrangement Agreement”) with Tilray Brands, Inc.

HEXO Corp. Announces Acquisition by Tilray Brands

Cronos Group

Neptune Wellness Solutions Inc.

Ready To Invest In Cannabis? 3 Marijuana Stocks To Watch The post 3 Marijuana Stocks To Watch Before The Close appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

3 Marijuana Stocks To Watch Before The Close

Aurora Cannabis

Canopy Growth

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

High Tide

Jazz Pharmaceuticals

OrganiGram Holdings Inc.

SNDL Inc.

Trulieve Cannabis Corp.

This developing industry has ample opportunity and sustained tailwinds. Very few U.S. companies have positive operating margins; very few of their Canadian counterparts have positive gross margins.

Finding The Long-Term Winners In The Cannabis Sector

Best Canadian Pot Stocks For April? The post Canadian Marijuana Stocks To Buy: 3 Penny Stocks On Watch For April appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Canadian Marijuana Stocks To Buy: 3 Penny Stocks On Watch For April

HEXO Corp. (NASDAQ:HEXO ) Q2 2023 Earnings Conference Call March 17, 2023 10:00 AM ET Company Participants Charlie Bowman – President and Chief Executive Officer Julius Ivancsits – Chief Financial Officer Conference Call Participants Matt Bottomley – Canaccord Genuity Frederico Gomes – ATB Capital Markets Aaron Grey – Alliance Global Partners Operator Good morning. I would like to welcome everyone to HEXO Corp's Second Quarter 2023 Conference Call.

HEXO Corp. (HEXO) Q2 2023 Earnings Call Transcript

HEXO (HEXO) delivered earnings and revenue surprises of 13.64% and 33.97%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?

HEXO (HEXO) Reports Q2 Loss, Lags Revenue Estimates

GATINEAU, Québec--(BUSINESS WIRE)--HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) ("HEXO" or the “Company"), a leading producer of high-quality cannabis products, today reported its financial results for the second quarter of the 2023 fiscal year (“Q2'23”). All currency amounts are stated in Canadian dollars unless otherwise noted.

HEXO Reports Q2'23 Financial Results

GATINEAU, Québec--(BUSINESS WIRE)--HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) ("HEXO" or the “Company"), a leading producer of high-quality cannabis products, announced today that it will hold an audio only conference call on March 17, 2023, at 10 a.m. EDT, to review its financial results for the second fiscal quarter, ended January 31, 2023. The results will be released after market close on Thursday, March 16, 2023. Following the prepared remarks, there will be a question-and-answer session.

HEXO to Host Second Quarter 2023 Earnings Conference Call

Canadian Pot Stocks For Watchlist This Week The post Are Canadian Cannabis Stock A Buy In March? 3 To Watch This Week appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Are Canadian Cannabis Stock A Buy In March? 3 To Watch This Week

HEXO (HEXO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will HEXO (HEXO) Report Negative Q2 Earnings? What You Should Know

Are You Watching Canadian Pot Stocks? The post Canadian Marijuana Stocks For 2023? 3 Penny Stocks To Watch appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Canadian Marijuana Stocks For 2023? 3 Penny Stocks To Watch

Top Penny Pot Stocks Under $2 For Traders In March The post Top Marijuana Penny Stocks With The Best Year To Date Performance In 2023 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Marijuana Penny Stocks With The Best Year To Date Performance In 2023

Are Canadian Cannabis Stocks On Your List For March? The post Top Marijuana Stocks To Watch On The Nasdaq Before March appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Marijuana Stocks To Watch On The Nasdaq Before March

Greenlane Holdings

Pot Stocks To Watch Next Week The post Best Cannabis Penny Stocks To Watch Before March Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

News for HEXO Corp Stock (HEXO)